SB 20 New Mexico Senate · 2026 Regular Session

PRIOR AUTHORIZATION & PRESCRIPTION DRUGS

SB 20 would change how health insurers and pharmacy benefits managers handle prior authorization for prescription drugs in New Mexico. It prohibits requiring prior authorization for medications treating serious mental illnesses (such as schizophrenia, depression, or bipolar disorder), ensuring patients can access these drugs without delays. For drugs managing chronic conditions (like diabetes or high blood pressure), the bill limits prior authorization reviews to once every three years instead of more frequent checks. The law also requires the state insurance office to standardize the process, create a uniform form for requests, and monitor compliance to prevent unnecessary delays in care.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
Senate Passage
Feb 2026
House Passage
Feb 2026
Signed into Law
Mar 2026
Introduced Jan 26, 2026 Signed Mar 6, 2026
Maddy AI version diff · 3 comparisons

What changed between versions

PA substitute Final Version · 5 edits
MODERATE
This bill amends New Mexico's Prior Authorization Act to prohibit prior authorization for certain prescription drugs used to treat serious mental illness and chronic health conditions, while limiting prior authorization for other drugs. The changes expand protections for patients with serious mental illnesses and chronic conditions by removing barriers to accessing necessary medications.
Scope change
The bill expands protections to cover drugs treating serious mental illness and chronic health conditions, which were not explicitly protected in the original version.
DEFINITION

Added new definitions for 'chronic maintenance drug' and 'serious mental illness' to clarify which medications and conditions are protected from prior authorization requirements.

Added definitions for 'auto-adjudicate' and 'pend' to clarify how prior authorization decisions can be made using technology or held for further review.

Modified the definition of 'chronic health condition' to specify conditions lasting one or more years that require ongoing medical attention or limit daily activities.

REQUIREMENT

Modified the Prior Authorization Act to prohibit prior authorization for drugs treating serious mental illness and chronic health conditions, making it harder for insurers to delay or deny access to these medications.

Modified the Prior Authorization Act to limit prior authorization for other drugs that treat chronic health conditions, reducing administrative barriers for patients with ongoing medical needs.

Floor votes · Senate Feb 12, 2026 · House Feb 18, 2026

How they voted

321
Passed · 5 other
Total votes 38
Feb 12, 2026
D Democratic22
19 Yea 3
86% Yea
R Republican16
13 Yea 1 Nay 2
81% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
10
Key actions
7
Committee
3
Mar 6, 2026
Signed into law
Signed
executive
Feb 19, 2026
Lower · Passed
passed House
lower
Feb 18, 2026
House · Passed
House Vote: pass (39-6-21)
house
Feb 16, 2026
Lower · Passed
DO PASS committee report adopted
lower
Feb 12, 2026
Upper · Passed
passed Senate
upper
Feb 12, 2026
Introduced
Sent to House Health & Human Services Committee
lower
Feb 11, 2026
Upper · Passed
DO NOT PASS, replaced with committee substitute
upper
Feb 7, 2026
Upper · Passed
DO NOT PASS, replaced with committee substitute
upper
Jan 26, 2026
Introduced
Sent to Senate Committees' Committee & Senate Health and Public Affairs Committee & Senate Tax, Business and Transportation Committee
upper
4 primary · 0 co-sponsors

Sponsors